Makoto Nakamuta

10.5k total citations
217 papers, 6.6k citations indexed

About

Makoto Nakamuta is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Makoto Nakamuta has authored 217 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Epidemiology, 114 papers in Hepatology and 48 papers in Molecular Biology. Recurrent topics in Makoto Nakamuta's work include Liver Disease Diagnosis and Treatment (96 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (39 papers). Makoto Nakamuta is often cited by papers focused on Liver Disease Diagnosis and Treatment (96 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (39 papers). Makoto Nakamuta collaborates with scholars based in Japan, United States and Germany. Makoto Nakamuta's co-authors include Munechika Enjoji, Kazuhiro Kotoh, Motoyuki Kohjima, Masaki Kato, Ryoichi Takayanagi, Hajime Nawata, Lawrence Chan, Nobito Higuchi, Naohiko Harada and Tsuyoshi Yoshimoto and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Makoto Nakamuta

211 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makoto Nakamuta Japan	42	3.6k	2.2k	1.9k	1.3k	1.2k	217	6.6k
Samuele De Minicis Italy	39	4.3k 1.2×	3.2k 1.4×	1.8k 1.0×	1.3k 1.0×	1.1k 0.9×	57	7.1k
Jacquelyn J. Maher United States	40	3.2k 0.9×	2.9k 1.3×	2.0k 1.1×	1.3k 1.0×	773 0.7×	97	6.8k
Satoru Saito Japan	42	4.6k 1.3×	2.5k 1.1×	1.0k 0.5×	1.5k 1.1×	1.4k 1.2×	221	6.8k
Toshiji Saibara Japan	39	4.2k 1.2×	2.2k 1.0×	1.3k 0.7×	868 0.7×	1.8k 1.5×	169	6.4k
Cynthia D. Guy United States	38	5.5k 1.5×	2.3k 1.0×	2.1k 1.1×	1.2k 0.9×	2.2k 1.9×	104	7.7k
Yuichiro Eguchi Japan	40	4.8k 1.3×	3.0k 1.3×	981 0.5×	1.0k 0.8×	1.6k 1.4×	178	6.7k
Alexander Wree Germany	35	3.5k 1.0×	1.5k 0.7×	2.6k 1.4×	779 0.6×	875 0.7×	90	6.0k
Mariana Verdelho Machado Portugal	36	4.9k 1.4×	1.8k 0.8×	2.1k 1.1×	927 0.7×	1.9k 1.6×	90	6.7k
Prithi S. Bhathal Australia	35	3.1k 0.9×	1.6k 0.7×	1.0k 0.5×	1.7k 1.3×	1.2k 1.0×	122	6.1k
Christoph H. Österreicher Austria	26	3.2k 0.9×	2.7k 1.2×	2.0k 1.1×	1.2k 0.9×	452 0.4×	37	6.8k

Countries citing papers authored by Makoto Nakamuta

Since Specialization

Citations

This map shows the geographic impact of Makoto Nakamuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Nakamuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Nakamuta more than expected).

Fields of papers citing papers by Makoto Nakamuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Nakamuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Nakamuta. The network helps show where Makoto Nakamuta may publish in the future.

Co-authorship network of co-authors of Makoto Nakamuta

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Nakamuta. A scholar is included among the top collaborators of Makoto Nakamuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Nakamuta. Makoto Nakamuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hamada, Shohei, Eikichi Ihara, Taisuke Sasaki, et al.. (2023). Importance of preoperative total colonoscopy and endoscopic resection after self-expandable metallic stent placement for obstructive colorectal cancer as a bridge-to-surgery. BMC Gastroenterology. 23(1). 251–251. 3 indexed citations

Fujimori, Nao, Masayuki Hijioka, Ken Kawabe, et al.. (2022). The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center. Clinical Endoscopy. 55(6). 784–792. 1 indexed citations

Ogawa, Eiichi, Hideyuki Nomura, Makoto Nakamuta, et al.. (2020). Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B. Liver International. 40(7). 1578–1589. 37 indexed citations

Ogawa, Eiichi, Norihiro Furusyo, Eiji Kajiwara, et al.. (2015). Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non‐cirrhotic patients with chronic hepatitis C virus genotype 1b infection. Journal of Gastroenterology and Hepatology. 30(12). 1759–1767. 8 indexed citations

Enjoji, Munechika, Motoyuki Kohjima, Kazuhiro Kotoh, & Makoto Nakamuta. (2012). Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments. International Journal of Hepatology. 2012. 1–7. 11 indexed citations

Kohjima, Motoyuki, Ryoko Yada, Akinobu Taketomi, et al.. (2011). 230 METABOLIC GENES IN HEPATOCELLULAR CARCINOMA. Journal of Hepatology. 54. S95–S96. 1 indexed citations

Ogawa, Eiichi, Norihiro Furusyo, Eiji Kajiwara, et al.. (2011). Evaluation of the adverse effect of premature discontinuation of pegylated interferon α‐2b and ribavirin treatment for chronic hepatitis C virus infection: Results from Kyushu University Liver Disease Study. Journal of Gastroenterology and Hepatology. 27(7). 1233–1240. 29 indexed citations

Kainuma, Mosaburo, Norihiro Furusyo, Koichi Azuma, et al.. (2011). Pegylated interferon α‐2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase. Hepatology Research. 42(1). 33–41. 3 indexed citations

Enjoji, Munechika, Masatake Tanaka, Masayuki Miyazaki, et al.. (2009). Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease. American Journal of Case Reports. 10. 145–148. 1 indexed citations

10.

Furusyo, Norihiro, Eiji Kajiwara, Kazuhiro Takahashi, et al.. (2008). Association between the treatment length and cumulative dose of pegylated interferon alpha‐2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group. Journal of Gastroenterology and Hepatology. 23(7pt1). 1094–1104. 41 indexed citations

11.

Kotoh, Kazuhiro, Makoto Nakamuta, Marie Fukushima, et al.. (2007). Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD.. PubMed. 54(73). 224–8. 3 indexed citations

12.

Nakamuta, Makoto. (2005). Effects of fibril- or fixed-collagen on matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 production in the human hepatocyte cell line HLE. World Journal of Gastroenterology. 11(15). 2264–2264. 10 indexed citations

13.

Okada, Makoto, Takeaki Satoh, Jirô Watanabe, et al.. (2005). Autoimmune hepatitis induced by pravastatin: two cases. Kanzo. 46(3). 133–141. 2 indexed citations

14.

Fukushima, Marie, Munechika Enjoji, Motoyuki Kohjima, et al.. (2005). Adipose differentiation related protein induces lipid accumulation and lipid droplet formation in hepatic stellate cells. In Vitro Cellular & Developmental Biology - Animal. 41(10). 321–324. 41 indexed citations

15.

Enjoji, Munechika, Manabu Nakashima, Koji Yamaguchi, Kazuhiro Kotoh, & Makoto Nakamuta. (2005). Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas. Journal of Gastroenterology and Hepatology. 20(8). 1143–1148. 22 indexed citations

16.

Furusyo, Norihiro, Norihiko Kubo, Kazuhiro Toyoda, et al.. (2005). Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C. Antiviral Research. 67(1). 46–54. 21 indexed citations

17.

Nakamuta, Makoto, Shusuke Morizono, Yuji Soejima, et al.. (2005). Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation. Transplantation. 80(5). 608–612. 100 indexed citations

18.

Enjoji, Munechika, Makoto Nakamuta, Koji Yamaguchi, et al.. (2004). CASE REPORT: RCAS1, a Useful Serum Marker to Predict the Recurrence of Cancer: Two Cases of Cholangiocarcinoma and Pancreatic Cancer. Digestive Diseases and Sciences. 49(10). 1654–1656. 8 indexed citations

19.

Chang, Benny Hung‐Junn, Wei Liao, Lan Li, et al.. (1999). Liver-specific Inactivation of the Abetalipoproteinemia Gene Completely Abrogates Very Low Density Lipoprotein/Low Density Lipoprotein Production in a Viable Conditional Knockout Mouse. Journal of Biological Chemistry. 274(10). 6051–6055. 108 indexed citations

20.

Nakamuta, Makoto, et al.. (1994). Benign recurrent intrahepatic cholestasis: a long-term follow-up.. PubMed. 41(3). 287–9. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact